Kim et al. demonstrates that the upregulation of CST1 in CRC contributes to colorectal tumorigenesis by neutralizing the inhibitory effect of CST3 on cathepsin B’s proteolytic activity. This evidence concerns the gene CST3 and colorectal carcinoma.